Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lancaster Resources Inc. C.LCR

Alternate Symbol(s):  LANRF

Lancaster Resources Inc. is a Canada-based company engaged in exploring lithium and uranium and other critical minerals. The Company’s Alkali Flat Lithium Project, which covers approximately 5,200 acres in Lordsburg, New Mexico, United States, and is involved in the exploration of a below-surface lithium brine target. The Company holds a 100% interest in the Catley Lalk and Centennial East Uranium project in the Athabasca Basin in Saskatchewan, Canada. The two properties, named Catley Lake and Centennial East, cover over 3,036 and 5,081 hectares respectively. Its project portfolio also includes rights to acquire the Trans-Taiga Lithium Property located within the James Bay lithium district of Quebec and covers over 3,520 acres. The Company’s Piney Lake Gold Property covers an area of 2,267.8 hectares, is nestled approximately 65 kilometers east of La Ronge Provincial Park and a mere 2.5 km east of North Arrow Minerals' Pikoo property.


CSE:LCR - Post by User

Post by ajmancion Feb 06, 2021 1:08am
272 Views
Post# 32491917

Fantastic opp here

Fantastic opp here

This company has an incredibly valuable intellectual property portfolio and is essentially the only company now doing research on the relation between psilocybin and obesity, with a good chance of yielding results. They would effectively corner a market with a major lack of effective treatments if the current trial pans out (the obesity market). In addition, they have a top notch clincial team (feel free to look them - well published, well regarded scientists and academics).

Valuation only $30 million now where the avg R&D based name in the psychadelic space is $130 million with big names like MMED over a billion. Money will flow in here big time.
 

As for management, plenty of concern re: Penny White, but they replaced her with Robert Tessarolo, who has a good track record and led MMED during its early days. He left because the co-owners of the company wanted to take over after it went public and they did not see the need for an industry outsider when they were capable. The Intellectual property portfolio and clinical team is the real value here and it will send this higher as money flows generally into the sector. They also have a small product based business (mushroom coffees) to provide near-term revenue. If this is revalued to simply match its peers, this is a $1+ dollar stock

<< Previous
Bullboard Posts
Next >>